{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:33:03Z","timestamp":1766853183954,"version":"3.48.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011917","name":"Hormozgan University of Medical Sciences","doi-asserted-by":"publisher","award":["4030037"],"award-info":[{"award-number":["4030037"]}],"id":[{"id":"10.13039\/501100011917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10645-6","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T07:08:45Z","timestamp":1748675325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of a germline variant of uncertain significance (MRE11:c.1138C\u2009>\u2009T) identified by exome sequencing in a cancer-affected individual and co-segregation analysis in affected and unaffected family members"],"prefix":"10.1007","volume":"52","author":[{"given":"Mohammadreza","family":"Saberiyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Seyedtaghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Mojodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azim","family":"Nejatizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"issue":"3","key":"10645_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263","journal-title":"Cancer J Clin"},{"key":"10645_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15\u201323","journal-title":"Breast"},{"issue":"1","key":"10645_CR3","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345","journal-title":"CA Cancer J Clin"},{"key":"10645_CR4","doi-asserted-by":"publisher","first-page":"5592802","DOI":"10.1155\/2024\/5592802","volume":"2024","author":"F Lotfi","year":"2024","unstructured":"Lotfi F, Ravankhah Z, Rashidian H, Teimouri F, Maracy MR, Javanmard SH et al (2024) The Cancer incidence pattern in Isfahan Province: an industrial region in the central part of Iran. J Cancer Epidemiol 2024:5592802","journal-title":"J Cancer Epidemiol"},{"key":"10645_CR5","doi-asserted-by":"publisher","first-page":"103851","DOI":"10.1016\/j.breast.2024.103851","volume":"79","author":"L Liao","year":"2025","unstructured":"Liao L (2025) Inequality in breast cancer: global statistics from 2022 to 2050. Breast 79:103851","journal-title":"Breast"},{"issue":"3","key":"10645_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"Cancer Incidence","year":"2022","unstructured":"Global Burden of Disease Cancer C, Cancer Incidence (2022) Mortality, years of life lost, years lived with disability, and Disability-Adjusted life years for 29 Cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019. JAMA Oncol 8(3):420\u2013444","journal-title":"JAMA Oncol"},{"issue":"3","key":"10645_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/annonc\/mdn642","volume":"20","author":"SM Mousavi","year":"2009","unstructured":"Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z (2009) Cancer incidence and mortality in Iran. Ann Oncol 20(3):556\u2013563","journal-title":"Ann Oncol"},{"issue":"3","key":"10645_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/2159-8290.CD-23-1091","volume":"14","author":"C Cobaleda","year":"2024","unstructured":"Cobaleda C, Godley LA, Nichols KE, Wlodarski MW, Sanchez-Garcia I (2024) Insights into the molecular mechanisms of genetic predisposition to hematopoietic malignancies: the importance of Gene\u2013Environment interactions. Cancer Discov 14(3):396\u2013405","journal-title":"Cancer Discov"},{"key":"10645_CR9","doi-asserted-by":"crossref","unstructured":"Pourmasoumi P, Moradi A, Bayat MJRS (2024) BRCA1\/2 mutations and breast\/ovarian cancer risk: a new insights review.:1\u201311","DOI":"10.1007\/s43032-024-01666-w"},{"issue":"2","key":"10645_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14636778.2014.914849","volume":"33","author":"Y Joly","year":"2014","unstructured":"Joly Y, Tonin PN (2014) Social, ethical and legal considerations Raised by the discovery and Patenting of the BRCA1 and BRCA2 genes. New Genet Soc 33(2):167\u2013180","journal-title":"New Genet Soc"},{"issue":"1","key":"10645_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y et al (2024) Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct Target Therapy 9(1):149","journal-title":"Signal Transduct Target Therapy"},{"key":"10645_CR12","doi-asserted-by":"crossref","unstructured":"Barili V, Ambrosini E, Bortesi B, Minari R, De Sensi E, Cannizzaro IR et al (2024) Genetic basis of breast and ovarian cancer: approaches and lessons learnt from three decades of inherited predisposition testing. Genes (Basel).;15(2)","DOI":"10.3390\/genes15020219"},{"issue":"7","key":"10645_CR13","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1158\/0008-5472.CAN-20-0177","volume":"81","author":"P Zhang","year":"2021","unstructured":"Zhang P, Kitchen-Smith I, Xiong L, Stracquadanio G, Brown K, Richter PH et al (2021) Germline and somatic genetic variants in the p53 pathway interact to affect Cancer risk, progression, and drug response. Cancer Res 81(7):1667\u20131680","journal-title":"Cancer Res"},{"issue":"1","key":"10645_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13148-024-01762-3","volume":"16","author":"E Klibaner-Schiff","year":"2024","unstructured":"Klibaner-Schiff E, Simonin EM, Akdis CA, Cheong A, Johnson MM, Karagas MR et al (2024) Environmental exposures influence multigenerational epigenetic transmission. Clin Epigenetics 16(1):145","journal-title":"Clin Epigenetics"},{"issue":"4","key":"10645_CR15","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/mef2.70001","volume":"3","author":"OS Sahoo","year":"2024","unstructured":"Sahoo OS, Aidasani H, Nayek A, Tripathi S, Talukdar J, Gul A et al (2024) Role of next-generation sequencing in revolutionizing healthcare for cancer management. MedComm\u2013 Future Med 3(4):e70001","journal-title":"MedComm\u2013 Future Med"},{"key":"10645_CR16","doi-asserted-by":"publisher","first-page":"101153","DOI":"10.1016\/j.mam.2022.101153","volume":"91","author":"CE Hopkins","year":"2023","unstructured":"Hopkins CE, Brock T, Caulfield TR, Bainbridge M (2023) Phenotypic screening models for rapid diagnosis of genetic variants and discovery of personalized therapeutics. Mol Aspects Med 91:101153","journal-title":"Mol Aspects Med"},{"issue":"2","key":"10645_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cge.13966","volume":"100","author":"S Makhnoon","year":"2021","unstructured":"Makhnoon S, Bednar EM, Krause KJ, Peterson SK, Lopez-Olivo MA (2021) Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis. Clin Genet 100(2):119\u2013131","journal-title":"Clin Genet"},{"issue":"6","key":"10645_CR18","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","volume":"109","author":"LH Goetz","year":"2018","unstructured":"Goetz LH, Schork NJ (2018) Personalized medicine: motivation, challenges, and progress. Fertil Steril 109(6):952\u2013963","journal-title":"Fertil Steril"},{"issue":"3","key":"10645_CR19","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.mcpro.2024.100737","volume":"23","author":"J Su","year":"2024","unstructured":"Su J, Yang L, Sun Z, Zhan X (2024) Personalized drug therapy: innovative concept guided with proteoformics. Mol Cell Proteom 23(3):100737","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"10645_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41523-021-00350-5","volume":"7","author":"A Alblihy","year":"2021","unstructured":"Alblihy A, Shoqafi A, Toss MS, Algethami M, Harris AE, Jeyapalan JN et al (2021) Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers. Npj Breast Cancer 7(1):143","journal-title":"Npj Breast Cancer"},{"issue":"1","key":"10645_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-019-1100-5","volume":"18","author":"L Bian","year":"2019","unstructured":"Bian L, Meng Y, Zhang M, Li D (2019) MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Mol Cancer 18(1):169","journal-title":"Mol Cancer"},{"key":"10645_CR22","doi-asserted-by":"crossref","unstructured":"Otahalova B, Volkova Z, Soukupova J, Kleiblova P, Janatova M, Vocka M et al (2023) Importance of germline and somatic alterations in human MRE11, RAD50, and NBN genes coding for MRN complex. Int J Mol Sci.;24(6)","DOI":"10.3390\/ijms24065612"},{"issue":"6","key":"10645_CR23","doi-asserted-by":"publisher","first-page":"e100041","DOI":"10.1371\/journal.pone.0100041","volume":"9","author":"R Koppensteiner","year":"2014","unstructured":"Koppensteiner R, Samartzis EP, Noske A, von Teichman A, Dedes I, Gwerder M et al (2014) Effect of MRE11 loss on PARP-Inhibitor sensitivity in endometrial Cancer in vitro. PLoS ONE 9(6):e100041","journal-title":"PLoS ONE"},{"issue":"8","key":"10645_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/oncolo\/oyae149","volume":"29","author":"DC Pavlick","year":"2024","unstructured":"Pavlick DC, Frampton GM, Ross JR (2024) Understanding variants of unknown significance and classification of genomic alterations. Oncologist 29(8):658\u2013666","journal-title":"Oncologist"},{"issue":"7","key":"10645_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jgo.2020.01.001","volume":"11","author":"Y Chavarri-Guerra","year":"2020","unstructured":"Chavarri-Guerra Y, Slavin TP, Longoria-Lozano O, Weitzel JN (2020) Genetic cancer predisposition syndromes among older adults. J Geriatric Oncol 11(7):1054\u20131060","journal-title":"J Geriatric Oncol"},{"key":"10645_CR26","first-page":"1431","volume":"136","author":"AK Siraj","year":"2017","unstructured":"Siraj AK, Masoodi T, Bu R, Parvathareddy SK, Al-Badawi IA, Al-Sanea N et al (2017) Expanding Spectr Germline Variants cancer 136:1431\u20131444","journal-title":"Expanding Spectr Germline Variants cancer"},{"key":"10645_CR27","doi-asserted-by":"crossref","unstructured":"Krogh BO, Llorente B, Lam A, Symington LSJG (2005) Mutations in Mre11 phosphoesterase motif I that impair Saccharomyces cerevisiae Mre11-Rad50-Xrs2 complex stability in addition to nuclease activity. 171(4):1561\u20131570","DOI":"10.1534\/genetics.105.049478"},{"key":"10645_CR28","doi-asserted-by":"crossref","unstructured":"D\u00e9ry U, Coulombe Y, Rodrigue Al, Stasiak A, Richard Sp, Masson J-YJM et al (2008) A glycine-arginine domain in control of the human MRE11 DNA repair protein","DOI":"10.1128\/MCB.02025-07"},{"key":"10645_CR29","doi-asserted-by":"crossref","unstructured":"Yu Z, Vogel G, Coulombe Y, Dubeau D, Spehalski E, H\u00e9bert J et al (2012) The MRE11 GAR motif regulates DNA double-strand break processing and ATR activation. 22(2):305\u2013320","DOI":"10.1038\/cr.2011.128"},{"key":"10645_CR30","doi-asserted-by":"crossref","unstructured":"Park YB, Chae J, Kim YC, Cho YJS (2011) Crystal structure of human Mre11: Understanding tumorigenic mutations. 19(11):1591\u20131602","DOI":"10.1016\/j.str.2011.09.010"},{"key":"10645_CR31","doi-asserted-by":"crossref","unstructured":"Delia D, Piane M, Buscemi G, Savio C, Palmeri S, Lulli P et al (2004) MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder. 13(18):2155\u20132163","DOI":"10.1093\/hmg\/ddh221"},{"key":"10645_CR32","doi-asserted-by":"crossref","unstructured":"Damiola F, Pertesi M, Oliver J, Le Calvez-Kelm F, Voegele C, Young EL et al (2014) Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a breast Cancer family registry case-control mutation-screening study. 16:1\u201316","DOI":"10.1186\/bcr3669"},{"key":"10645_CR33","doi-asserted-by":"crossref","unstructured":"Tarapara B, Shah FJJoBS (2023) Dynamics. An in-silico analysis to identify structural, functional and regulatory role of SNPs in hMRE11. 41(6):2160\u20132174","DOI":"10.1080\/07391102.2022.2028678"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10645-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:31:41Z","timestamp":1766853101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10645"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10645-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following approval from the Ethics Committee of Hormozgan University of Medical Sciences (approval code: \" IR.HUMS.REC.1403.133\u201d) and the study protocols performed in accordance with the relevant guidelines and regulations. Also the Declaration of Helsinki was performed (Association, 2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"530"}}